Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.12.1731

Effects of Cholic Acid/CDCA and FGF-19 on the Protein Levels of the Endogenous Small Heterodimer Partner (SHP) in the Mouse Liver and HepG2 Cells  

Min, Gye-Sik (Department of Pharmaceutical Engineering, Jinju National University)
Publication Information
Journal of Life Science / v.19, no.12, 2009 , pp. 1731-1736 More about this Journal
Abstract
Recent studies determined that a chronic western-style diet increased the endogenous small heterodimer partner (SHP) protein levels in mice. In experiments with cell cultures, chenodeoxy cholic acid (CDCA) treatment increased endogenous SHP protein levels and reduced the degradation rate of exogenously expressed flag-SHP levels in the human hepatoma cell line, HepG2 cells. In addition, bile acid-induced intestinal fibroblast growth factor-19 (FGF-19) increased the half-life of the exogenously expressed SHP when HepG2 cells were transfected with ad-flag-SHP. However, both the expression level and the degradation rate of the endogenous SHP in response to cholic acid and FGF-19 have not been well understood, either in mice or in cultured HepG2 cells. This study examined the effects of cholic acid treatment on the endogenous SHP protein levels in mice and the effects of FGF-19 on the degradation rate of the endogenous SHP protein in HepG2 cells. Mice fed 0.5% cholic acid in normal chow showed an increase in endogenous SHP protein levels during both 12 hr and 24 hr treatment periods as compared to control mice fed only normal chow. In cultured HepG2 cells, treatment with CDCA did not noticeably change the rate of degradation in the endogenous SHP protein from cells not treated with CDCA. Although consistent with the previous studies on the exogenous ad-flag-SHP protein, treatment with FGF-19 significantly decreased the degradation rate of the endogenous SHP protein when HepG2 cells were treated with cyclohexamide. These results suggest that both bile acids and FGF-19 increase the endogenous SHP protein levels in mouse liver and HepG2 cells.
Keywords
CDCA; cholic acid; endogenous SHP; FGF-19;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kemper, L H. Kim, J. Miao, S. Bhalla, and Y. Bae. 2004. Role of a mSin3A-Swi/Snf chromatin remodeling complex in the feedback repression of bile acid biosynthesis by SHP. Mol. Cell BioI. 24, 7707-7719   DOI   ScienceOn
2 Kerr, T. A, S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D. W. Russell, and M. Schwarz. 2002. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Developmental Cell 2, 713-720   DOI   ScienceOn
3 Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6, 507-515   DOI   ScienceOn
4 Miao, L Z. Xiao, D. Kanamaluru, G. Min, P. M. Yau, T. D. Veenstra, E. Ellis, S. Strom, K. Suino-Powelt H. E. Xu, J. K. Kemper. 2009. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteosomal degradation. Genes Dev. 23, 986-996   DOI   ScienceOn
5 Russell, D. W. 1999. Nuclear orphan receptors control cholesterol catabolism. Cell 97, 539-542   DOI   ScienceOn
6 Wang, L., Y. Lee, D. Bundman, Y. Han, S. Thevananther, C. Kim, S. Chua, P. Wei, R. Heyman, M. Karin, and D. Moore. 2002. Redundant pathways for negative feedback regulation of bile acid production. Developmental Cell 2, 721-731   DOI   ScienceOn
7 Chiang, J. Y. L. 2002. Bile acid regulation of gene expression: Roles of nuclear hormone receptors. Endocr. Rev. 23, 443-463   DOI   ScienceOn
8 Fang, S., J. Miao, L. Xiang, B. Ponugoti, E. Treuter, and J. K. Kemper. 2007. Coordinated recruitment of histone methyltransferase G9a and other chromatin modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. Mol. Cell BioI. 27, 1407-1424   DOI   ScienceOn
9 Goodwin, B., S. A Jones, R. R. Price, M. A Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, and et al. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6, 517-526   DOI   ScienceOn
10 Gupta, S., T. Stravitz, P. Dent, and P. Hylemon. 2001. Down-regulation of cholesterol 7 a-hydroxylase (CYP7 A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-jun N-terminal kinase pathway. J. BioI. Chem. 276, 15816-15822   DOI   ScienceOn
11 Holt, J. A, G. Luo, A N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A Mansfield, S. A Kliewer, and et al. 2003. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581-1591   DOI   ScienceOn
12 Houten, S. M., M. Watanabe, and J. Auwerx. 2006. Endocrine functions of bile acids. EMBO. J. 25, 1419-1425   DOI   ScienceOn
13 Jelinek, D. F., S. Andersson, C. A Slaughter, and D. W. Russell. 1990. Cloning and regulation of cholesterol 7alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. BioI. Chem. 265, 8190-8197
14 Inagaki, T., M. Choi, A Moschetta, L. Peng, C. L. Cummins, J. G. McDonald, G. Luo, S. A Jones, B. Goodwin, J. A Richardson, et al. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225   DOI   ScienceOn